miRBind

miRBind predicts miRNA:target-site binding using a deep learning classifier trained on seed-agnostic experimental data to identify canonical and non-canonical interactions mediated by the Argonaute (Ago) protein family.


Key Features:

  • Deep learning model: Uses a deep learning classifier to perform miRNA:target-site binding classification.
  • Seed-agnostic training: Trained on seed-agnostic experimental data to capture interactions that do not follow canonical seed rules.
  • Canonical and non-canonical detection: Identifies both canonical seed-based and non-canonical binding sites.
  • Argonaute-mediated interactions: Models interactions that are mediated by the Argonaute (Ago) protein family.
  • Comparison to traditional approaches: Moves beyond seed-based heuristics and co-folding free-energy calculations and reports improved prediction accuracy over those methods.
  • Binding classification focus: Produces binary or probabilistic predictions of miRNA:target-site binding potential.

Scientific Applications:

  • miRNA-mediated gene regulation: Improves identification of miRNA targets for studies of post-transcriptional gene regulation.
  • Disease mechanism investigation: Facilitates analysis of miRNA involvement in disease-related regulatory changes.
  • Therapeutic target discovery: Supports discovery and prioritization of miRNA-related therapeutic targets.
  • Experimental prioritization: Prioritizes candidate binding sites, including non-canonical sites, for experimental validation.

Methodology:

Trains a deep learning classifier on seed-agnostic experimental data to classify miRNA:target-site binding while not relying on seed-centric heuristics or co-folding free-energy calculations.

Topics

Details

Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
2/22/2023
Last Updated:
11/24/2024

Operations

Publications

Klimentová E, Hejret V, Krčmář J, Grešová K, Giassa I, Alexiou P. miRBind: A Deep Learning Method for miRNA Binding Classification. Genes. 2022;13(12):2323. doi:10.3390/genes13122323. PMID:36553590. PMCID:PMC9777820.

PMID: 36553590
PMCID: PMC9777820
Funding: - Grantová Agentura České Republiky: 19-10976Y